139 results on '"Morishita R"'
Search Results
2. Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia
3. Visualizing septin and cell dynamics in mammalian brain slices
4. Quantitative Observation of Strain Localisation in a Partially Saturated Triaxial Specimen Using Microfocus X-ray CT with Image Analysis
5. NFκB Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases
6. Potential of Transcription Factor Decoy Oligonucleotides as Therapeutic Approach
7. A novel antithrombotic vaccine against S100A9 without risks of bleeding in ischemic stroke in mice
8. PP.13.27
9. PP.06.27
10. Vitamin B12 absorption studies with plastic whole body counter in patients with gastroenterological operation
11. Involvement of Uronic Acid in Calcium-Induced Aggregation of Deaggregated Water-Insoluble Protein of Human Lens
12. P336: Alpha-synuclein, causative molecule of Parkinson’s disease, plays significant pathophysiological roles in aging-related metabolic syndrome
13. Generation of Coherent Phonons in a CdTe Single Crystal Using an Ultrafast Two-Phonon Laser-Excitation Process
14. Erratum: Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells
15. Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse
16. PGE2‐EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF‐κB
17. Dysbindin-1, a schizophrenia-related molecule, is involved in the regulation of neuronal dendritic development
18. Dysbindin-1, WAVE2 and Abi-1 form a complex that regulates dendritic spine formation
19. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells
20. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia
21. Abstract: P261 URSODEOXYCHOLIC ACID INHIBITS ENDOTHELIAL CELL PLASMINONEN ACTIVATOR INHIBITOR-1 EXPRESSION INDUCED BY HIGH GLUCOSE
22. Pharmacological treatment of abdominal aortic aneurysm
23. P.275 Application of NFkB decoy ODNs to bone destruction disease
24. TRANSFECTION OF NF ƒÛB DECOY OLIGODEOXYNUCLEOTIDES USING “EFFICIENT ULTRASOUND - GENE TRANSFER” INTO DONOR KIDNEYS PROLONGED SURVIVAL OF RAT RENAL ALLOGRAFTS
25. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NF B and E2F in a rabbit model
26. Alleviation of Aβ-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model
27. Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element
28. Essential roles of ERK-mediated phosphorylation of vinexin in cell spreading, migration and anchorage-independent growth
29. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis
30. O.007 Application of NFκB decoy oligonucleotides to bone metabolic diseases – In vitro and in vivo studies
31. Prevention of onset of Parkinson’s disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson’s disease
32. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy
33. Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet
34. NFκB decoy oligodeoxynucleotides ameliorates osteoporosis through inhibition of activation and differentiation of osteoclasts
35. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFκB and ets using chimeric decoy oligonucleotides in a rabbit model
36. Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter
37. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease
38. Inhibition of ets, an essential transcription factor for angiogenesis, to prevent the development of abdominal aortic aneurysm in a rat model
39. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound
40. Effect of nifedipine on endothelial function in normotensive smokers: potential contribution of increase in circulating hepatocyte growth factor
41. Antisense Oligonucleotides as a Powerful Molecular Strategy for Gene Therapy in Cardiovascular Diseases
42. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo
43. INCREASE IN DNA SYNTHESIS OF CARDIAC MYOCYTES BYTRANSFECTION OF ANTISENSE P53 AND RB OLIGODEOXYNUCLEOTIDES(ODN);POSSIBILITY OF REGENERATION OF CARDIAC MYOCYTES
44. INHIBITION OF NEOINTIMAL FORMATION BY BERAPROST SODIUM (BPS) IN THE PORCINE CORONARY ARTERY AFTER BALLOON INJURY
45. ENHANCED THERAPEUTIC ANGIOGENESIS BY CO-TRANSFECTION OF PROSTACYCLIN SYNTHASE GENE
46. ANTI-APOPTIC EFFECTS OF HEPATOCYTE GROWTH FACTOR IMPROVE HEART FUNCTION AND MORTALITY AGAINST DOXORUBICIN-INDUCED HEART FAILURE
47. IMIDAPRIL PREVENTED ATHEROSCLEROTIC CHANGES DUE TO HYPERTENSION AND DIABETES IN RATS
48. RESULTS OF SAFETY FROM HUMAN CLINICAL GENE THERAPY USING HGF (TREAT-HGF)
49. VEGF (164) INDUCES TRANSFORMATION OF BLOOD CELLS PRECURSORS INTO ENDOTHEUAL CELLS IN DEVELOPING POSTERIOR BLOOD ISLAND
50. EFFICACY OF THERAPEUTIC ANGIOGENESIS BYTRANSFECTION OF HEPATOCYTE GROWTH FACTOR GENE USING LEFT VENTRICULAR ELECTROMECHANICAL MAPPING IN PORCINE MYOCARDIAL INFARCTION MODEL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.